Dutch DSM Q2 net profit surges to €112m, net sales grow 9%

06 August 2013 06:46  [Source: ICIS news]

SINGAPORE (ICIS)--DSM’s second-quarter net profit surged to €112m ($149m) from €41m in the same period last year, backed by a 9% increase in net sales, the Dutch specialty chemicals firm said on Tuesday.

Net sales for the three months ending June 2013 increased to €2.49bn from €2.27bn in the previous corresponding period, the company said in a statement.

DSM’s core net profit for the quarter grew 32% year on year to €156m, it said.

“Materials Sciences' profit remained at the same level as last year despite a negative caprolactam impact of €20m and a challenging market environment," DSM CEO and chairman Feike Sijbesma said in the statement.

 Earnings before interest, tax, depreciation and amortisation (EBITDA) in the June quarter 2013 rose 19% year on year to €345m, about 72% of which came from DSM’s nutrition segment, it said.

Its nutrition business generated €249m in earnings, up 28% year on year, while performance materials had a 6% increase in earnings at €82m in the three months to June 2013.

From polymer intermediates, second-quarter earnings fell 13% to €26m, while pharmaceuticals’ earnings declined 18% to €14m, the company said.

“We expect strong EBITDA growth in 2013, moving towards €1.4bn,"  Sijbesma said.

($1 = €0.75)


By: Pearl Bantillo
+65 6780 4359



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly